Juvenile idiopathic arthritis - change or first continuing treatment due to critical shortage of tocilizumab authority application form (PB322)

Use this form to apply to change or first continuing PBS-subsidised treatment with adalimumab or etanercept for juvenile idiopathic arthritis.

Download and complete the Juvenile idiopathic arthritis - change or first continuing treatment due to critical shortage of tocilizumab authority application form.

To fill in this form digitally you will need a computer and Adobe Acrobat Reader, or a similar program. You can download Adobe Acrobat Reader for free. If you can’t complete the form digitally, you can print it, complete it by hand and return it to us following the instructions on the form.

You can upload this form in HPOS.

If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.

Page last updated: 23 September 2022